An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes

Allergan

Status: Completed

Conditions: Eyelash Hypotrichosis

Treatments: Drug: bimatoprost 0.03%

Study type: Observational

Funder types: Industry

Identifiers

NCT01623479

GMA-LTS-10-001

CED2009 (Other Identifier)

Details and patient eligibility

About

This is an observational study of patients treated with bimatoprost 0.03% (Latisse®) for at least 12 months for hypotrichosis of the eyelashes.

Enrollment: 585 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hypotrichosis of the eyelashes
• Using bimatoprost ophthalmic solution 0.03% (Latisse®) for at least 12 months

Exclusion criteria

• Use of any over-the-counter medication(s) for eyelash growth

Trial design

585 participants in 1 patient group

Hypotrichosis of the Eyelashes

Description:

Subjects with hypotrichosis of the eyelashes using bimatoprost 0.03% (Latisse®) as prescribed by physician for at least 12 months

Treatment:

Drug: bimatoprost 0.03%